FDA Guidance Provides New Details on Diversity Action Plans Required for Certain Clinical Studies

/PRNewswire/ — Today, the U.S. Food and Drug Administration issued a draft guidance, “Diversity Action Plans to Improve Enrollment of Participants from…
Share This Post
Related Articles

The PTS Blog

Subscribe to our blog to stay up to date on the latest HCM, Data, Recruiting, Technology, and Software trends.

Top Posts From PTS
Explore

View our White Papers

View our Case Studies

Receive the latest updates

Subscribe To
Our Quarterly Newsletter

Get notified about new blog posts, case studies, white papers, and more!